Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-23-077601
Filing Date
2023-07-03
Accepted
2023-07-03 16:08:53
Documents
37

Document Format Files

Seq Description Document Type Size
1 S-1/A tm237052-11_s1a.htm S-1/A 3559510
2 EXHIBIT 1.1 tm237052d12_ex1-1.htm EX-1.1 211589
3 EXHIBIT 3.2 tm237052d12_ex3-2.htm EX-3.2 81482
4 EXHIBIT 3.4 tm237052d12_ex3-4.htm EX-3.4 153658
5 EXHIBIT 10.24 tm237052d12_ex10-24.htm EX-10.24 19784
6 EXHIBIT 23.1 tm237052d12_ex23-1.htm EX-23.1 1958
7 GRAPHIC bc_biomarkerimaging-4c.jpg GRAPHIC 75573
8 GRAPHIC bc_collagen-4c.jpg GRAPHIC 126647
9 GRAPHIC bc_denifanstat-4c.jpg GRAPHIC 31490
10 GRAPHIC bc_fibrosisbio-4c.jpg GRAPHIC 53177
11 GRAPHIC bc_fibrosiss-4c.jpg GRAPHIC 55214
12 GRAPHIC bc_fig29liver-4c.jpg GRAPHIC 98817
13 GRAPHIC bc_fig30elfandldl-4c.jpg GRAPHIC 99733
14 GRAPHIC bc_inflammation-4c.jpg GRAPHIC 85489
15 GRAPHIC bc_lipidbio-4c.jpg GRAPHIC 56927
16 GRAPHIC bc_lipotoxicity-4c.jpg GRAPHIC 115107
17 GRAPHIC bc_liverfatbio-4c.jpg GRAPHIC 96998
18 GRAPHIC bc_pipeline01-4c.jpg GRAPHIC 150781
19 GRAPHIC bc_solidtumors-4c.jpg GRAPHIC 88587
20 GRAPHIC bc_tripalmitin-4c.jpg GRAPHIC 26859
21 GRAPHIC bc_weekdosing-4c.jpg GRAPHIC 88246
22 GRAPHIC fc_clinicaltrial-4c.jpg GRAPHIC 73450
23 GRAPHIC fc_clinicaltrial4c.jpg GRAPHIC 66855
24 GRAPHIC fc_denifanstat-4c.jpg GRAPHIC 83698
25 GRAPHIC fc_diseaserationale-4c.jpg GRAPHIC 142821
26 GRAPHIC fc_excessliver-4c.jpg GRAPHIC 83370
27 GRAPHIC fc_metabolic-4c.jpg GRAPHIC 58576
28 GRAPHIC fc_overview-4c.jpg GRAPHIC 97317
29 GRAPHIC fc_pathogenesis-4c.jpg GRAPHIC 177297
30 GRAPHIC fc_patients-4c.jpg GRAPHIC 148180
31 GRAPHIC fc_precision-4c.jpg GRAPHIC 116752
32 GRAPHIC lc_predictive-4c.jpg GRAPHIC 53447
33 GRAPHIC lg_sagimet-4c.jpg GRAPHIC 40042
34 GRAPHIC ph_denifanstat-4c.jpg GRAPHIC 174205
35 GRAPHIC tb_fibrogenic-4c.jpg GRAPHIC 67467
36 GRAPHIC tb_oncology-4c.jpg GRAPHIC 127756
37 GRAPHIC tb_treatment-4c.jpg GRAPHIC 142382
  Complete submission text file 0001104659-23-077601.txt   7921208
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-272901 | Film No.: 231065358
SIC: 2834 Pharmaceutical Preparations